⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

TMO

Thermo Fisher Scientific Inc.

Healthcare · Diagnostics & Research

605.69USD

+2.6700 (+0.44%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗

Computing valuation metrics…

Valuation

P/E (TTM)

32.14x

P/E (Forward)

22.00x

EV/EBITDA

28.23x

EV/Revenue

5.67x

P/S (TTM)

4.83x

P/B

4.25x

FCF Yield

3.27%

Dividend Yield

0.31%

Gross Margin

24.45%

Operating Margin

17.58%

Net Margin

15.04%

Peer Comparison — Diagnostics & Research

CompanyMkt CapP/EEV/EBITDAFCF YieldRev GrowthDiv Yield
TMOThermo Fisher Scientific Inc.$223.95B32.14x28.23x3.27%10.49%0.31%
DHRDanaher Corporation$144.01B36.58x20.90x3.00%5.50%0.78%

Subject metrics from SEC filings where available; peer metrics from cached market data.

IQVIQVIA Holdings Inc.
$42.30B
31.96x
18.69x
5.08%
8.70%
—
AAgilent Technologies, Inc.$40.81B28.55x21.05x2.60%8.10%0.69%
IDXXIDEXX Laboratories, Inc.$40.58B36.15x25.58x2.24%9.70%—
WATWaters Corporation$39.75B102.48x30.66x-0.36%113.40%—
ILMNIllumina, Inc.$30.95B38.25x27.98x2.58%9.40%—
LHLabcorp Holdings Inc.$26.04B26.58x14.11x3.43%5.80%0.89%
DGXQuest Diagnostics Incorporated$25.99B25.00x14.19x3.50%10.20%1.46%